SG10201807682PA - Methods of Treating or Preventing Respiratory Conditions - Google Patents

Methods of Treating or Preventing Respiratory Conditions

Info

Publication number
SG10201807682PA
SG10201807682PA SG10201807682PA SG10201807682PA SG10201807682PA SG 10201807682P A SG10201807682P A SG 10201807682PA SG 10201807682P A SG10201807682P A SG 10201807682PA SG 10201807682P A SG10201807682P A SG 10201807682PA SG 10201807682P A SG10201807682P A SG 10201807682PA
Authority
SG
Singapore
Prior art keywords
treating
respiratory
methods
subject
preventing respiratory
Prior art date
Application number
SG10201807682PA
Other languages
English (en)
Inventor
Ravi Krishnan
Peter Ghosh
Silviu Itescu
Original Assignee
Mesoblast Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mesoblast Inc filed Critical Mesoblast Inc
Publication of SG10201807682PA publication Critical patent/SG10201807682PA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
SG10201807682PA 2012-12-12 2013-12-12 Methods of Treating or Preventing Respiratory Conditions SG10201807682PA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261736352P 2012-12-12 2012-12-12

Publications (1)

Publication Number Publication Date
SG10201807682PA true SG10201807682PA (en) 2018-10-30

Family

ID=50933587

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201807682PA SG10201807682PA (en) 2012-12-12 2013-12-12 Methods of Treating or Preventing Respiratory Conditions
SG11201504352TA SG11201504352TA (en) 2012-12-12 2013-12-12 Methods of treating or preventing respiratory conditions

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201504352TA SG11201504352TA (en) 2012-12-12 2013-12-12 Methods of treating or preventing respiratory conditions

Country Status (11)

Country Link
US (3) US10028979B2 (enExample)
EP (1) EP2931373B1 (enExample)
JP (5) JP6313327B2 (enExample)
KR (1) KR101748712B1 (enExample)
CN (2) CN115919901A (enExample)
AU (4) AU2013360026B2 (enExample)
CA (1) CA2893951C (enExample)
ES (1) ES2759281T3 (enExample)
IL (1) IL239309A0 (enExample)
SG (2) SG10201807682PA (enExample)
WO (1) WO2014089625A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2893951C (en) 2012-12-12 2022-05-03 Mesoblast, Inc. Methods of treating or preventing respiratory conditions
US20170296589A1 (en) * 2014-09-23 2017-10-19 Case Western Reserve University Compositions and methods for treating lung remodeling diseases
WO2019051536A1 (en) * 2017-09-15 2019-03-21 Cynata Therapeutics Limited METHOD OF TREATING ALLERGIC RESPIRATORY TRACT DISEASE (DAA) / ASTHMA
EP4098267A4 (en) * 2020-01-30 2024-03-06 JCR Pharmaceuticals Co., Ltd. MEDICINAL COMPOSITION COMPRISING CELLS DERIVED FROM DENTAL PULP
JP7551341B2 (ja) * 2020-06-04 2024-09-17 株式会社三共 遊技機
JP7551340B2 (ja) * 2020-06-04 2024-09-17 株式会社三共 遊技機
CN118800458B (zh) * 2024-09-14 2024-11-15 吉林大学 一种心胸外科术后并发症预测方法及系统

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003901668A0 (en) * 2003-03-28 2003-05-01 Medvet Science Pty. Ltd. Non-haemopoietic precursor cells
AU2003207399A1 (en) * 2002-02-19 2003-09-09 Medipost Co., Ltd. Isolation and culture-expansion methods of mesenchymal stem/progenitor cells from umbilical cord blood, and differentiation method of umbilical cord blood-derived mesenchymal stem/progenitor cells into various mesenchymal tissues
US20080095749A1 (en) * 2004-03-22 2008-04-24 Sudeepta Aggarwal Mesenchymal stem cells and uses therefor
TR201900968T4 (tr) * 2004-09-24 2019-02-21 Mesoblast Inc Multipotansiyel genleşmiş mezenkimal prekürsör hücre soyu (memp) ve bunların kullanımı.
US8367405B2 (en) * 2005-04-12 2013-02-05 Mesoblast, Inc. Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase
US20120269774A1 (en) 2006-09-21 2012-10-25 Medistem Laboratories, Inc Allogeneic stem cell transplants in non-conditioned recipients
US20090053182A1 (en) * 2007-05-25 2009-02-26 Medistem Laboratories, Inc. Endometrial stem cells and methods of making and using same
CN103169731A (zh) * 2007-08-06 2013-06-26 成血管细胞系统公司 用于体内生成、修复和/或维护结缔组织的方法
ES2595103T3 (es) * 2007-10-17 2016-12-27 Txcell Células Tr1, células madre mesenquimales y usos de estas
SG193888A1 (en) * 2008-09-03 2013-10-30 Mesoblast Inc Expansion of haemopoietic precursors
KR101871472B1 (ko) * 2010-07-02 2018-06-27 메소블라스트, 아이엔씨. 이식편대숙주 질환의 치료 방법
KR102063069B1 (ko) * 2011-03-11 2020-01-08 칠드런'즈 메디컬 센터 코포레이션 중간엽 줄기 세포 엑소솜에 관련된 방법 및 조성물
EP2714057B1 (en) * 2011-06-03 2019-11-06 Mesoblast, Inc. Methods of treating or preventing neurological diseases
CA2893951C (en) 2012-12-12 2022-05-03 Mesoblast, Inc. Methods of treating or preventing respiratory conditions

Also Published As

Publication number Publication date
AU2022209219A1 (en) 2022-08-18
AU2022209219B2 (en) 2025-08-14
HK1210077A1 (en) 2016-04-15
US20200289578A1 (en) 2020-09-17
AU2013360026B2 (en) 2018-06-21
EP2931373A4 (en) 2016-05-04
CA2893951C (en) 2022-05-03
KR20150090237A (ko) 2015-08-05
ES2759281T3 (es) 2020-05-08
EP2931373A1 (en) 2015-10-21
CA2893951A1 (en) 2014-06-19
US10028979B2 (en) 2018-07-24
JP2022065132A (ja) 2022-04-26
JP2016502980A (ja) 2016-02-01
JP7420844B2 (ja) 2024-01-23
US10688134B2 (en) 2020-06-23
KR101748712B1 (ko) 2017-06-19
EP2931373B1 (en) 2019-08-21
JP6665218B2 (ja) 2020-03-13
AU2018226514B2 (en) 2020-01-02
CN105377274A (zh) 2016-03-02
US20150306146A1 (en) 2015-10-29
AU2020202022A1 (en) 2020-04-09
CN115919901A (zh) 2023-04-07
JP6313327B2 (ja) 2018-04-18
WO2014089625A1 (en) 2014-06-19
SG11201504352TA (en) 2015-07-30
US20190046575A1 (en) 2019-02-14
IL239309A0 (en) 2015-07-30
JP2018118987A (ja) 2018-08-02
JP2020097618A (ja) 2020-06-25
AU2018226514A1 (en) 2018-09-27
JP2024041904A (ja) 2024-03-27
AU2013360026A1 (en) 2015-07-02

Similar Documents

Publication Publication Date Title
BR112013011827A2 (pt) ''respirador com peça facial filtrante que tem uma vedação facial moldada com sobreposição''
BR112013011108A2 (pt) ''respirador de peça facial filtrante que tem uma estrutura de suporte moldada por injeção á estrutura filtrante''
IL234508B (en) Inhalation of nitric oxide for treating respiratory diseases
IL221873A (en) Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd
EP2560681A4 (en) USE OF TAU FOR MONITORING IMMUNOTHERAPY
EP2528934A4 (en) AROMATIC-CATIONIC PEPTIDES AND USES THEREOF
MX337437B (es) Composiciones topicas para conservador o restaurar la integridad de la mucosa.
NZ778131A (en) Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
EP2793993A4 (en) RECOVERY AND PROCESSING OF HUMAN IN VIVO EMBRYOS
PH12013500892A1 (en) Composition for use in the prevention and/or treatment of skin conditions and skin diseases
TN2012000511A1 (en) Compositions and methods of use for therapeutic low density lipoprotein -related protein 6 (lrp6) antibodies
IL234101B (en) Compositions comprising acamprosate and baclofen for use in the treatment of parkinsonism
PT2888280T (pt) Anticorpos humanos para gfrα3 humano e métodos de uso dos mesmos
SG195110A1 (en) Pirfenidone and anti-fibrotic therapy in selected patients
NZ719185A (en) Crystalline forms of therapeutic compounds and uses thereof
PH12013502149A1 (en) Modified acid alpha glucosidase with accelerated processing
EP3257943A3 (en) Methods and vectors for cell immortalisation
WO2012047951A3 (en) Human lung stem cells and uses thereof
PH12013501671A1 (en) Methods for improving brain development and cognitive function using beta-hydroxy-beta-methylbutyrate
IN2014CN00795A (enExample)
MX363507B (es) Metodos para administrar óxido nítrico a la sangre arterial o arterializada.
NZ602380A (en) Peptides for vaccine against birch allergy
MX2011008179A (es) Peptidos para vacuna.
PL2892556T3 (pl) Kompozycje i sposoby odnoszące się do leczenia chorób
MX2015005111A (es) Composicion a base de hierbas para la prevencion y tratamieto de tnf-a una enfermedad mediada.